Gene · 1871
Papers3,808
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,808
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| circFIG 4 drives the carcinogenesis and metastasis of esophagus cancer via the miR-493-5p/E2F3 axis. | Thorac Cancer | 2022 | 35083866 | PubTator, text mining | PubMed |
| Uncovering serum placental-related non-coding RNAs as possible biomarkers of preeclampsia risk, onset and severity revealed MALAT-1, miR-363 and miR-17. | Sci Rep | 2022 | 35075166 | PubTator, text mining | PubMed |
| Mutually exclusive mutation profiles define functionally related genes in muscle invasive bladder cancer. | PLoS One | 2022 | 35073341 | PubTator, text mining | PubMed |
| CBX2 and EZH2 cooperatively promote the growth and metastasis of lung adenocarcinoma. | Mol Ther Nucleic Acids | 2022 | 35070495 | PubTator, text mining | PubMed |
| The lncRNAs at X Chromosome Inactivation Center: Not Just a Matter of Sex Dosage Compensation. | Int J Mol Sci | 2022 | 35054794 | PubTator, text mining | PubMed |
| HELLS Is Negatively Regulated by Wild-Type P53 in Liver Cancer by a Mechanism Involving P21 and FOXM1. | Cancers (Basel) | 2022 | 35053620 | PubTator, text mining | PubMed |
| A Signature of 14 Long Non-Coding RNAs (lncRNAs) as a Step towards Precision Diagnosis for NSCLC. | Cancers (Basel) | 2022 | 35053601 | PubTator, text mining | PubMed |
| The Role of Epstein-Barr Virus in Modulating Key Tumor Suppressor Genes in Associated Malignancies: Epigenetics, Transcriptional, and Post-Translational Modifications. | Biomolecules | 2022 | 35053275 | PubTator, text mining | PubMed |
| Long non‑coding RNA CTBP1‑AS2 upregulates USP22 to promote pancreatic carcinoma progression by sponging miR‑141‑3p. | Mol Med Rep | 2022 | 35039872 | PubTator, text mining | PubMed |
| Suppression of RNA editing by miR-17 inhibits the stemness of melanoma stem cells. | Mol Ther Nucleic Acids | 2022 | 35036056 | PubTator, text mining | PubMed |
| Securin overexpression correlates with the activated Rb/E2F1 pathway and histone H3 epigenetic modifications in raw areca nut-induced carcinogenesis in mice. | Cancer Cell Int | 2022 | 35033090 | PubTator, text mining | PubMed |
| Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers. | Mol Ther Oncolytics | 2022 | 35024437 | PubTator, text mining | PubMed |
| Loss of CMTM6 promotes DNA damage-induced cellular senescence and antitumor immunity. | Oncoimmunology | 2022 | 35024247 | PubTator, text mining | PubMed |
| New insights into the interplay between long non-coding RNAs and RNA-binding proteins in cancer. | Cancer Commun (Lond) | 2022 | 35019235 | PubTator, text mining | PubMed |
| eIF4A3-induced circWAC promotes breast cancer progression through mediating miR-599/E2F3 axis. | Kaohsiung J Med Sci | 2022 | 34989110 | PubTator, text mining | PubMed |
| Smad3 deficiency improves islet-based therapy for diabetes and diabetic kidney injury by promoting β cell proliferation via the E2F3-dependent mechanism. | Theranostics | 2022 | 34987651 | PubTator, text mining | PubMed |
| Systems Biology and Bioinformatics approach to Identify blood based signatures molecules and drug targets of patient with COVID-19. | Inform Med Unlocked | 2022 | 34981034 | PubTator, text mining | PubMed |
| The roles of long non-coding RNAs in lung cancer. | J Cancer | 2022 | 34976181 | PubTator, text mining | PubMed |
| MiR-192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF-κB pathway. | Thorac Cancer | 2022 | 34953057 | PubTator, text mining | PubMed |
| Circular RNA circ_0000644 promotes papillary thyroid cancer progression via sponging miR-1205 and regulating E2F3 expression. | Cell Cycle | 2022 | 34919034 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1871/papers?page=40